Researchers developed an mRNA vaccine targeting glypican-2, a protein found on neuroblastoma cells. In preclinical studies, ...

A new study from RCSI University of Medicine and Health Sciences demonstrates a novel approach in anticancer vaccine development. The results, published in Molecular Therapy Oncology, present the ...

TG-MVA builds on Transgene’s expertise in MVA (Modified Vaccinia Ankara) viral vectors, which are well established in smallpox vaccines development Extensive data with TG-MVA CEF and TG-MVA CL ...

Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or ...

As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current ...

Combining cutting-edge proprietary technologies and enhanced manufacturing, TG4070 is positioned as a novel vaccine relevant to multiple tumor ...

Tonix Pharmaceuticals presented positive preclinical data for TNX-801, a single-dose vaccine against mpox and smallpox, at a recent conference. Tonix Pharmaceuticals has presented encouraging ...

Leishmaniasis is present in approximately 200 countries worldwide, being a major public health problem primarily in the ...

The search for potent malaria vaccine candidate has seen several twists and turns. Here, we provide a perspective on the current state of PfRH5-based malaria vaccine development, the progress, ...

FLORHAM PARK, N.J., Jan. 27, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease ...

Unlike the more common Zaire strain, for which approved vaccines and treatments exist, there are currently no specific ...

There have been recent funding announcements which have created optimism among scientists and health officials. Several vaccine candidates are now moving through different stages of development.